Plant Ozone Oil

Dosage for ozone is not measured in milligrams like a tablet, but rather in concentration (micrograms per milliliter, µg/mL) and total volume (milliliters, mL). The specific dose depends entirely on the procedure being performed.

• Intra-articular (Joint) Injection: Typically, a concentration of 10–20 µg/mL is used, with a volume ranging from 5 mL to 20 mL depending on the size of the joint (e.g., small finger joint vs. large knee joint).
• Intradiscal Injection: For spinal procedures, concentrations are usually higher (20–35 µg/mL), but the volume is much smaller, often only 2–5 mL, to avoid over-pressurizing the spinal disc.
• Subcutaneous Administration: For localized pain, small volumes of 1–3 mL at concentrations of 5–10 µg/mL may be used.

Ozone is generally not approved for pediatric use in a diagnostic or therapeutic capacity. The safety and efficacy of ozone gas in children have not been established through rigorous clinical trials. Pediatric patients are more sensitive to oxidative stress, and the risk of accidental inhalation or systemic toxicity is significantly higher. Healthcare providers will almost always opt for alternative contrast agents or imaging modalities (such as MRI or Ultrasound) that do not involve gaseous contrast in children.

Renal Impairment

Because ozone is not cleared by the kidneys, no specific dose adjustments are required for patients with renal failure. However, the patient's overall stability must be assessed, as renal patients may have altered antioxidant capacities.

Hepatic Impairment

No dosage adjustments are formally established for patients with liver disease. Since ozone metabolism occurs locally and via blood-borne antioxidants, the liver's role in its clearance is minimal.

Elderly Patients

Elderly patients may have thinner skin and more fragile vascular structures. While the dose of ozone gas does not necessarily change, the technique of administration must be more cautious to prevent accidental intravascular injection, which can lead to gas embolism.

Ozone is never self-administered. It is strictly a professional-use-only gas.

1. 1Preparation: The clinician uses a medical-grade ozone generator to create a precise mixture of oxygen and ozone.
2. 2Administration: The gas is drawn into a sterile, ozone-resistant syringe (usually glass or specialized plastic).
3. 3Procedure: Under fluoroscopic (X-ray) or ultrasound guidance, the clinician inserts a needle into the target area and slowly injects the gas.
4. 4Post-Procedure: The patient is typically monitored for 15–30 minutes to ensure no adverse reactions or respiratory distress occurs.

Storage: Ozone cannot be stored. It must be used within minutes of generation, as it will revert to pure oxygen if left in a syringe for more than 20–30 minutes.

Since ozone is administered as a one-time procedure or a scheduled clinical treatment, 'missing a dose' in the traditional sense does not occur. If a scheduled procedure is missed, it should be rescheduled as soon as possible. There is no risk of 'withdrawal' or 'sub-therapeutic levels' from a single missed session.

An overdose of ozone can occur if the concentration is too high (leading to tissue necrosis) or the volume is too large (leading to compartment syndrome or embolism).

• Signs of Overdose: Severe localized pain, swelling, skin blanching, or, if inhaled, coughing and shortness of breath.
• Emergency Measures: If systemic toxicity is suspected, the administration must stop immediately. Oxygen therapy and supportive care for oxidative stress are initiated. In the event of a gas embolism, the patient may need to be placed in the Trendelenburg position (head down) or treated in a hyperbaric oxygen chamber.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or attempt to use ozone products without medical guidance.

When ozone is administered correctly as a contrast agent, side effects are generally localized to the site of injection. Common experiences include:

• Pressure Sensation: A feeling of fullness or 'tightness' in the joint or disc as the gas occupies space. This usually dissipates within 30 minutes as the gas begins to absorb.
• Local Crepitus: A 'crunching' or 'popping' sensation under the skin near the injection site, caused by small amounts of gas escaping into the subcutaneous tissue. This is harmless and resolves within 24 hours.
• Temporary Aching: A mild dull ache at the injection site that may last for a few hours following the procedure.

• Vasovagal Reaction: Fainting, dizziness, or lightheadedness triggered by the needle insertion or the sensation of the gas injection.
• Localized Redness: Mild inflammation or erythema (redness) at the needle entry point.
• Nerve Irritation: If the gas is injected near a nerve root (common in spinal procedures), it may cause a temporary 'zing' or tingling sensation down a limb.

• Infection (Iatrogenic): As with any injection, there is a risk of introducing bacteria into a joint or disc (septic arthritis or discitis).
• Tissue Necrosis: Occurs if excessively high concentrations of ozone are used, causing oxidative damage to healthy cells.
• Hyperesthesia: An increased sensitivity to touch in the area where the ozone was administered.

> Warning: Stop the procedure and call your doctor immediately if you experience any of these symptoms after an ozone administration.

• Gas Embolism: This is the most critical risk. If ozone gas enters a blood vessel, it can travel to the heart, lungs, or brain. Symptoms include sudden chest pain, shortness of breath, confusion, visual disturbances, or sudden weakness on one side of the body.
• Anaphylaxis: Though rare (since ozone is a form of oxygen), allergic reactions to the materials used during the procedure (like the needle or skin cleanser) can occur. Symptoms include hives, swelling of the throat, and difficulty breathing.
• Respiratory Distress: If ozone gas is accidentally inhaled during the procedure, it can cause pulmonary edema (fluid in the lungs). Symptoms include a persistent cough, wheezing, and blue-tinted lips (cyanosis).
• Severe Neurological Deficit: Sudden loss of bowel or bladder control or paralysis following a spinal ozone injection.

Because ozone is used intermittently and has an extremely short biological half-life, long-term systemic side effects are virtually unknown. However, repeated injections into the same joint over many years could theoretically lead to chronic oxidative changes in the synovial lining, though clinical data on this is sparse. There is no evidence that medical ozone use increases the risk of cancer or chronic organ failure when used according to established protocols.

No FDA black box warnings for Ozone. However, the FDA has issued several safety communications regarding 'Ozone Therapy' (the systemic use of ozone for non-approved conditions), warning that ozone is a toxic gas with no proven safe medical application in specific concentrations for certain diseases. When used as a Radiographic Contrast Agent, the primary warning is focused on the risk of gas embolism and the toxicity of inhalation.

Report any unusual symptoms, especially respiratory or neurological changes, to your healthcare provider immediately.

Ozone is a powerful oxidizing agent. Its safety depends entirely on the route of administration, the concentration, and the total volume used. It must never be inhaled, as the lungs lack the protective antioxidant coating found in other tissues, making them highly susceptible to ozone-induced damage. Patients must ensure that their procedure is performed by a licensed professional using a certified medical ozone generator that can precisely control gas concentrations.

No FDA black box warnings for Ozone as a radiographic contrast agent. It is important to distinguish between the FDA-cleared use of gases in imaging and the controversial 'ozone therapy' promoted for various systemic illnesses.

• Inhalation Toxicity: Ozone is a potent respiratory irritant. Even low concentrations can cause permanent lung damage if inhaled over time. The procedure room must be well-ventilated, and the delivery system must be closed to prevent gas leakage.
• Gas Embolism Risk: The most significant risk during any gas injection is the accidental introduction of the gas into the venous or arterial circulation. This can lead to a stroke, myocardial infarction (heart attack), or pulmonary embolism.
• Oxidative Stress: Patients with severely depleted antioxidant levels (e.g., severe malnutrition or certain genetic disorders) may be more sensitive to the oxidative effects of ozone.
• Hematologic Concerns: Ozone can affect platelet aggregation. Patients with bleeding disorders or those on high-dose anticoagulants should be monitored closely for local hematoma (bruising) at the injection site.

Before and after an ozone procedure, the following may be monitored:

• Oxygen Saturation (SpO2): To ensure no respiratory compromise occurred during the procedure.
• Blood Pressure and Heart Rate: To monitor for vasovagal reactions or stress-induced changes.
• Neurological Checks: Particularly for spinal injections, to ensure no nerve damage or embolism has occurred.
• Follow-up Imaging: To confirm the gas has dissipated and that the diagnostic goals were met.

Patients should not drive themselves home immediately after an ozone procedure, especially if it involved the spine or a weight-bearing joint. The physical discomfort of the injection, combined with the potential for a vasovagal reaction (fainting), may impair the ability to operate a vehicle safely. It is recommended to wait at least 2–4 hours and ensure full sensation and strength have returned.

There is no direct chemical interaction between alcohol and ozone gas. However, alcohol can increase peripheral vasodilation and potentially increase the risk of bruising at the injection site. It is generally advised to avoid alcohol for 24 hours before and after the procedure to ensure clear monitoring of any side effects.

Ozone is not a maintenance medication; therefore, 'discontinuation' involves simply stopping the series of procedures. There are no withdrawal symptoms. If a patient chooses to stop a course of ozone treatments, they should discuss alternative pain management or diagnostic options with their doctor.

> Important: Discuss all your medical conditions, especially respiratory issues like asthma or COPD, with your healthcare provider before starting Ozone.

While ozone is a gas and does not circulate like a pill, certain systemic conditions or substances can make its use dangerous:

• Acute Alcohol Intoxication: Increases the risk of respiratory depression and complicates the monitoring of potential gas embolism symptoms.
• Uncontrolled Hyperthyroidism: Ozone can slightly stimulate metabolic processes, which may exacerbate a thyroid storm in unstable patients.
• Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency: This is a critical contraindication. Patients with G6PD deficiency lack the ability to protect their red blood cells against oxidative stress. Exposure to ozone can trigger massive hemolysis (destruction of red blood cells).

• Antioxidant Supplements (High Dose): Supplements like Vitamin C, Vitamin E, and N-acetylcysteine (NAC) can neutralize the oxidative effects of ozone. While this might seem safe, it can actually render the ozone treatment ineffective if the goal is a specific biological response. Conversely, if these are depleted, the risk of ozone toxicity increases.
• Anticoagulants (Warfarin, Heparin, Eliquis): While there is no chemical interaction with the gas, the physical act of injection carries a much higher risk of internal bleeding (hematoma) in patients on these medications.

• ACE Inhibitors (Lisinopril, etc.): Some studies suggest that ACE inhibitors may increase sensitivity to the airway-constricting effects of inhaled ozone, which is relevant if accidental leakage occurs during the procedure.
• Chemotherapy Agents: Because many chemotherapy drugs rely on oxidative balance, the use of ozone should be timed carefully to avoid interfering with the cancer treatment's efficacy.

• Grapefruit: Unlike many oral drugs, ozone is not metabolized by the CYP3A4 enzyme, so grapefruit does not affect its levels.
• High-Fat Meals: No known interaction.
• Caffeine: May increase heart rate, which can be compounded by the stress of the injection procedure.

• St. John's Wort: No known interaction.
• Ginkgo Biloba / Garlic / Ginseng: These supplements have mild blood-thinning properties and may increase the risk of bruising at the injection site.

Ozone administration may transiently affect certain blood tests:

• Blood Glucose: Ozone may cause a temporary fluctuation in blood sugar readings due to its effect on glycolysis.
• Erythrocyte Sedimentation Rate (ESR): May be temporarily altered due to the oxidative effect on red blood cell membranes.
• Partial Pressure of Oxygen (PaO2): If systemic ozone therapy is used (off-label), it may temporarily increase oxygen readings in arterial blood gas tests.

For each interaction, the management strategy usually involves a 24-hour 'washout' period where the supplement or non-essential medication is paused, or simply increased clinical monitoring during the procedure.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially if you have G6PD deficiency.

Ozone must NEVER be used in patients with the following conditions:

1. 1G6PD Deficiency (Favism): As mentioned, the lack of the G6PD enzyme makes red blood cells highly vulnerable to oxidative rupture (hemolysis) upon contact with ozone or its metabolites. This can lead to life-threatening anemia and kidney failure.
2. 2Pregnancy (Acute): Due to the lack of safety data and the potential for oxidative stress to affect fetal development, ozone is absolutely contraindicated during pregnancy.
3. 3Active Internal Bleeding: The use of any injection-based contrast agent is prohibited in the presence of an active hemorrhage.
4. 4Recent Myocardial Infarction (Heart Attack): The physiological stress of the procedure and the risk of gas embolism make it too dangerous for patients who have had a heart attack within the last 3 months.
5. 5Ozone Allergy: While rare, any previous anaphylactic or severe reaction to medical ozone precludes its future use.

Conditions requiring careful risk-benefit analysis include:

• Severe Asthma or COPD: Due to the extreme sensitivity of the airways to any leaked ozone gas.
• Hyperthyroidism: Specifically if it is not well-controlled by medication.
• Active Systemic Infection: The risk of spreading the infection via the needle track must be weighed against the diagnostic benefit.
• Severe Thrombocytopenia: Very low platelet counts increase the risk of bleeding into the joint or disc space.

There are no direct cross-sensitivities with common drugs like penicillin or sulfa. However, patients who are highly sensitive to environmental pollutants (smog, ozone alerts) may experience more significant localized irritation or respiratory discomfort if even trace amounts of the gas are inhaled.

> Important: Your healthcare provider will evaluate your complete medical history, including any history of anemia or respiratory disease, before prescribing Ozone.

Ozone is classified as Pregnancy Category C (or equivalent). There are no adequate and well-controlled studies of ozone in pregnant women. Animal reproduction studies have not been conducted. It is unknown whether ozone can cause fetal harm or affect reproduction capacity. Because ozone is a potent oxidant and its metabolites can circulate systemically, it should be avoided entirely during pregnancy unless the diagnostic benefit clearly and significantly outweighs the potential risks to the fetus.

It is unknown whether ozone metabolites are excreted in human milk. Because many drugs and gases are excreted in milk and because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to discontinue nursing or to forgo the ozone procedure. Most clinicians recommend a 24-hour 'pump and dump' period following an ozone procedure as a precautionary measure.

Safety and effectiveness in pediatric patients have not been established. Ozone is not recommended for use in children due to the higher risk of pulmonary toxicity and the lack of standardized dosing for smaller joint/disc volumes. Alternative imaging modalities are preferred.

Clinical studies of ozone did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. In general, dose selection for an elderly patient should be cautious, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy. The risk of gas embolism may be higher in the elderly due to vascular stiffness and fragility.

No dosage adjustment is required for patients with renal impairment, as the kidneys are not involved in the primary clearance of ozone gas. However, clinicians should be aware that patients with end-stage renal disease often have compromised antioxidant defenses, which may theoretically increase the risk of localized oxidative damage.

No dosage adjustment is required for patients with hepatic impairment. The liver does not play a significant role in the breakdown of ozone. However, patients with severe liver failure (Child-Pugh Class C) may have coagulopathies (bleeding risks) that make the injection procedure more hazardous.

> Important: Special populations require individualized medical assessment and a thorough review of the risks associated with oxidative agents.

Ozone acts as a radiographic contrast agent through its physical property of low electron density. When injected into a body cavity, it displaces denser fluids and tissues. In an X-ray beam, the ozone gas allows more photons to pass through to the detector compared to the surrounding soft tissue, creating a 'negative' image (radiolucency).

At the biochemical level, ozone is a powerful oxidant. It reacts with the water and lipids in the synovial fluid or nucleus pulposus to create Reactive Oxygen Species (ROS) and Lipid Oxidation Products (LOPs). These molecules act as signal transducers, potentially inducing a mild inflammatory response that can lead to the release of growth factors and the activation of local antioxidant defenses. This 'oxidative burst' is the basis for its purported therapeutic effects in pain management.

• Onset: The contrast effect is immediate upon injection.
• Duration: The physical presence of the gas lasts between 30 minutes and 2 hours, depending on the vascularity of the tissue and the volume injected.
• Tolerance: There is no known pharmacological tolerance to the contrast effect of ozone, though repeated exposure to the lungs can lead to 'ozone desensitization,' which is a pathological rather than therapeutic effect.

| Parameter | Value |

|---|---|

| Bioavailability | 100% (Local) |

| Protein Binding | N/A (Reacts with proteins) |

| Half-life | < 30 minutes (Biological) |

| Tmax | Immediate |

| Metabolism | Spontaneous decomposition to O2 |

| Excretion | Exhalation (as O2) |

• Molecular Formula: O3
• Molecular Weight: 48.00 g/mol
• Solubility: 494 mg/L in water at 0°C; solubility decreases as temperature increases.
• Description: Ozone is a pale blue gas with a distinct, pungent odor (often described as 'chlorine-like' or 'the smell after a thunderstorm'). It is an allotrope of oxygen that is much less stable than the diatomic O2.

Ozone is classified as a Radiographic Contrast Agent [EPC]. It belongs to the group of gaseous contrast media, which also includes medical air, carbon dioxide, and oxygen. It is also categorized as a Non-Standardized Plant Allergenic Extract [EPC] when used in diagnostic allergy testing panels.